Australia, Aug. 6 -- Acadia Pharmaceuticals Inc., owns the trademark (2650908) for 'ACADIA' and 'RAYS FORM STAR' till March 2, 2036.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment and prevention of neurologic, rare neurologic, neuropsychiatric, rare neuropsychiatric, metabolic, rare metabolic, genetic, rare genetic, psychologic, rare psychologic, psychiatric, and rare psychiatric diseases and disorders.], 16 [Printed publications, namely, brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support.], 35 [Promoting awareness of patient support offerings for neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; promoting awareness of patient support offerings for pain associated with neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; business administration services in the field of healthcare, namely, business administration of reimbursement and medical benefit information for neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions and their treatment; business administration services in the field of healthcare, namely, business administration of reimbursement and medical benefit information for treatment of pain associated with neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions; business administrative services for medical referrals.], 41 [Educational services, namely, conducting programs in the field of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders and treatment and patient support options for these conditions.], 42 [Providing on-line non-downloadable software for administering medical benefits and enrolling in benefits patient support program services; biomedical research services; industrial research in the field of biotechnology; scientific research; scientific and technological services, namely, research and design in the field of biotechnology and biomedicine; providing scientific research information in the field of biotechnology and biomedicine; chemical, biochemical, biological and bacteriological research and analysis; biological research and analysis; testing of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; pharmaceutical research in the field of medical testing, namely, in vitro and in vivo preclinical testing of potential drugs; providing medical research information in the field of pharmaceuticals.] and 44 [Consultancy in the field of the medical treatment of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions; consultancy in the field of the medical diagnosis of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric conditions; medical information; providing medical information via a website; providing personalized healthcare and medical information in the nature of providing information about the therapeutic benefits of pharmaceutical products, medical information regarding disease management, and healthcare-related information to patients and healthcare professionals in the fields of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders; providing medical information in the field of neurologic, neuropsychiatric, metabolic, rare, genetic, psychologic, and psychiatric diseases and disorders.]
Type of Mark: Figurative
Date of Acceptance: May 29
Registration Advertised: Aug. 5
For further details contact PLLC Carissa L. Weiss Law Office of Carissa L. Weiss.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2650908.
Disclaimer: Curated by HT Syndication.
